Repotrectinib
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Repotrectinib
Sep 17, 2024, 15:07 |
Blog
Stephen V Liu: Data from ARROS-1 study of NVL-520 in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Benjamin Besse presents data from ARROS-1 study…
Jun 18, 2024, 02:59 |
Blog
Estela Rodriguez: Another tumor - agnostic approval
Estela Rodriguez shared a post on X: "Another tumor-agnostic approval. FDA Oncology grants accelerated approval…
Jun 16, 2024, 13:37 |
Drugs
Stephen Liu: FDA approves repotrectinib for NTRK fusion positive solid tumors
Stephen Liu recently shared a post on X: “FDA approves repotrectinib for NTRK fusion positive…
Jun 16, 2024, 05:49 |
Drugs
Vivek Subbiah: Another Tissue-Agnostic FDA approval
Vivek Subbiah shared on LinkedIn: . "Yes!…
Jan 16, 2024, 05:48 |
Drugs
Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Nov 21, 2023, 14:18 |
Drugs
5 new drug indications by FDA Oncology in the last 10 days - Oncology Brothers
Quoting Oncology Brothers on X/Twitter: "What just happened? 5 new drug indications by FDA Oncology…
All:
6
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube